✦ LIBER ✦

Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment

✍ Scribed by Jochen Graff, Sebastian Harder

Book ID: 120803236
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 456 KB
Volume: 52
Category: Article
ISSN: 0312-5963
DOI: 10.1007/s40262-013-0034-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favorable therapeutic index of the direc

Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

✍ P. C. WONG; E. J. CRAIN; C. A. WATSON; B. XIN 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Evaluation of the novel factor Xa inhibi

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

✍ Christian T. Ruff; Robert P. Giugliano; Elliott M. Antman; Sharon E. Crugnale; T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Surgery and invasive procedures in patie

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis

✍ Pierre Sié; Charles M. Samama; Anne Godier; Nadia Rosencher; Annick Steib; Juan 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 425 KB

Intracranial Hemorrhage Among Patients W

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

✍ Hankey, G. J.; Stevens, S. R.; Piccini, J. P.; Lokhnygina, Y.; Mahaffey, K. W.; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 920 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB

Letter by Apostolakis et al Regarding Ar

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 419 KB